 SAN DIEGO, March 08, 2022 GLOBE NEWSWIRE -- Bionano Genomics, Inc. BNGO, pioneer of optical genome mapping OGM solutions on the Saphyr system and provider of NxClinicalTM, a leading software solution for visualization, interpretation, and reporting of genomic data, announced today that company management will present virtually at the 32nd Annual Oppenheimer Healthcare Conference. Erik Holmlin, PhD, Bionanos president and chief executive officer, is scheduled to present a corporate overview on Tuesday, March 15th, 2022 at 5:40 am PT8:40 am ET. 